• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Nicholas inks drug supply deal with foreign firm

      Posted AtDNAIndia.com

      Nicholas Piramal Ltd, India's sixth-biggest drugmaker by market value, agreed to supply medicines to an unidentified "global hospital products company" for 10 years.

      Such deals, also called "custom manufacturing", are normally confidential in nature, and a slew of them have been struck between Indian pharma firms and multinationals that are trying to cut costs.

      Nicholas expects initial sales from the products to be between $12 million and $15 million a year. The revenues are expected to kick in from the middle of 2007. Sales from the company's so-called contract manufacturing business will account for 50% of total revenue by 2010, chairman Ajay Piramal said in a September interview.

      The agreement with the hospital company can be extended annually after 10 years, and can be expanded to include additional drugs.

      Nicholas already has agreements to supply health-care products to companies including Irvine, California-based Allergan Inc and Santa Ana, California-based Advanced Medical Optics Inc.

      After its second-quarter results, the company had said it expected to sign five such deals before December end. With Thursday's announcement, Nicholas has now signed two deals in two months. The first was with AstraZeneca in late October, under which it will develop active pharmaceutical ingredients used to make medicines.

      Under custom manufacturing, the whole process from development to commercialisation of a drug is customised according to the client's needs.

      Whereas in contract manufacturing, only the job to produce an active pharma ingredient is farmed out.

      In terms of revenue, custom manufacturing is lucrative, affording 20-25% margins. Apart from Nicholas, Hyderabad-based Dr Reddy's Laboratories, and the New Delhi-based Ind Swift Laboratories are some of the companies following the path.

      The advantage of this strategy is that revenue is assured, and the legal hassles that follow moves to produce patented drugs are avoided.

      November 25, 2005


      Share this Article!

    Back to top^